Medical Image Understanding and Analysis Conference 2020 Jul 15, 2020 - Jul 17, 2020 — Virtual Meeting (online)
CAFACHEM 2020 Summer School on Organic & Halogen Radiochemistry Aug 26, 2020 - Aug 28, 2020 — Virtual Meeting (online)
Scottish Dementia Research Consortium Annual Conference 2020 [rescheduled] Sep 07, 2020 10:00 AM - 04:00 PM — Radisson Blu, 301 Argyle St, Glasgow
Society for Magnetic Resonance Angiography - SMRA2020 VIRTUAL Sep 11, 2020 - Sep 13, 2020 — Virtual Meeting (online)

eLearning

SINAPSE experts from around Scotland have developed ten online modules designed to explain medical imaging. They are freely available and are intended for non-specialists.


Edinburgh Imaging Academy at the University of Edinburgh offers the following online programmes through a virtual learning environment:

Neuroimaging for Research MSc/Dip/Cert

Imaging MSc/Dip/Cert

PET-MR Principles & Applications Cert

Applied Medical Image Analysis Cert

Online Short Courses

Optimized response prediction in esophagogastric junction adenocarcinomas (EGJAc) with combination of molecular biomarkers and FDG-PET

Author(s): R.D. Petty, G. Bain, G.I. Murray, F. Gilbert, A.R. Denison, F. McKiddie, T. Ahearns, J. Leeds, P. Phull, K. Park, S. Nanthakumaran, A. Welch, L. Schweiger, Collie-Duguid

Abstract:
Background: Predictive biomarkers (BMs) for EGJAc would optimise treatment selection and avoid ineffective therapy. Metabolic response (MR) defined as >35% decrease in tumour FDG Standardized Uptake Value (SUV) between day 0 & 14 after starting chemotherapy has a high negative predictive value (95%) for response, but limited positive predictive value (50%). Combining molecular BMs with FDG-PET may optimise response prediction. We used global gene expression profiling (GEP) to identify molecular BMs that when combined with FDG-PET would improve predictive accuracy. Methods: 28 patients with locally advanced or metastatic EGJAc received platinum based chemotherapy (PBC). FDG PET CT scans were at day 0 and day 14 and GEP (Affymetrix ST1.0 Exon Genechips) on day 0 tumour biopsies. A tissue microarray comprising an independent set of 154 OGJAc who underwent surgery +/- neoadjuvant PBC was used with immunohistochemistry (IHC) for qualification of GEP results. Radiological response was assessed after 3/ 4 cycles of PBC by RECISTv1.1. Results: We identified a gene expression signature (86 genes) that separated FDG PET MR patients(>35% fall SUV day 0 to14) into those that do and do not go on to have a RECIST response. In cross validation, this signature correctly predicted response in 28/28. Pathway analysis on GEP data identified potential novel mechanisms of response, including the Leptin pathway. Leptin mRNA was higher in FDG metabolic responders who did not have a RECIST response compared to those that did. In the independent set, high Leptin protein by IHC was strongly associated with lack of histopathologic response to neoadjuvant PBC (n=64, p=0.002). High Leptin expression also had a therapy independent prognostic effect with longer survival in the absence of histopathologic response or with no neoadjuvant PBC and in low Leptin patients poor survival was mitigated to a certain extent by neoadjuvant PBC (n=154, Kaplan-Mieier, log rank p=0.041 & Cox MVA p=0.040). Conclusions: Molecular biomarkers (Leptin in particular) combine with FDG PET to optimise response prediction in EGJAc. Further investigation of this combined molecular and imaging approach is warranted.

Full version: Available here

Click the link to go to an external website with the full version of the paper


ISBN:
Publication Year: 2012
Periodical: Journal of Clinical Oncology
Periodical Number:
Volume: 30
Pages:
Author Address: